SG10201906475UA - Agent for improving early insulin secretory capacity - Google Patents

Agent for improving early insulin secretory capacity

Info

Publication number
SG10201906475UA
SG10201906475UA SG10201906475UA SG10201906475UA SG10201906475UA SG 10201906475U A SG10201906475U A SG 10201906475UA SG 10201906475U A SG10201906475U A SG 10201906475UA SG 10201906475U A SG10201906475U A SG 10201906475UA SG 10201906475U A SG10201906475U A SG 10201906475UA
Authority
SG
Singapore
Prior art keywords
agent
early insulin
secretory capacity
insulin secretory
improving early
Prior art date
Application number
SG10201906475UA
Other languages
English (en)
Inventor
Yasuto Yoshida
Eiichiro Naito
Satoru Kunihiro
Kouji Miyazaki
Original Assignee
Yakult Honsha Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Kk filed Critical Yakult Honsha Kk
Publication of SG10201906475UA publication Critical patent/SG10201906475UA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SG10201906475UA 2015-01-22 2016-01-21 Agent for improving early insulin secretory capacity SG10201906475UA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015010024 2015-01-22

Publications (1)

Publication Number Publication Date
SG10201906475UA true SG10201906475UA (en) 2019-08-27

Family

ID=56417184

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201906475UA SG10201906475UA (en) 2015-01-22 2016-01-21 Agent for improving early insulin secretory capacity
SG11201705174WA SG11201705174WA (en) 2015-01-22 2016-01-21 Agent for improving early insulin secretory capacity

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201705174WA SG11201705174WA (en) 2015-01-22 2016-01-21 Agent for improving early insulin secretory capacity

Country Status (6)

Country Link
JP (1) JP6670256B2 (fr)
KR (1) KR102497887B1 (fr)
CN (1) CN107106619A (fr)
MY (1) MY191218A (fr)
SG (2) SG10201906475UA (fr)
WO (1) WO2016117654A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190247450A1 (en) * 2016-10-28 2019-08-15 Kabushiki Kaisha Yakult Honsha Agent for inhibiting decrease in disease-free rate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0859492A (ja) 1994-08-26 1996-03-05 Yakult Honsha Co Ltd 抗糖尿病薬
JP2011193730A (ja) * 2010-03-17 2011-10-06 Yakult Honsha Co Ltd 多糖−ペプチドグリカン複合体保有乳酸菌の取得方法

Also Published As

Publication number Publication date
MY191218A (en) 2022-06-09
KR102497887B1 (ko) 2023-02-08
WO2016117654A1 (fr) 2016-07-28
CN107106619A (zh) 2017-08-29
JP6670256B2 (ja) 2020-03-18
JPWO2016117654A1 (ja) 2017-11-02
SG11201705174WA (en) 2017-07-28
KR20170103774A (ko) 2017-09-13

Similar Documents

Publication Publication Date Title
MX2017016819A (es) Composiciones antimicrobianas y sus usos.
PH12017500361B1 (en) Novel compounds
MX2022001292A (es) Composiciones enriquecidas estereoquimicamente para administracion de acidos nucleicos.
EP3659585A4 (fr) Composition pour administrer des substances physiologiquement actives dans un vaisseau sanguin
PH12017500416A1 (en) Compounds and compositions as raf kinase inhibitors
PH12017501019A1 (en) Isoxazole hydromaxamic acid compounds as lpxc inhibitors
NZ704125A (en) Bacillus megaterium bioactive compositions and metabolites
MX366561B (es) Composicion que contiene minoxidil para el crecimiento del pelo.
PH12017500708A1 (en) Probiotic and prebiotic compositions
MX2018003554A (es) Benzamidas sustituidas con isoxazolina y analogos como insecticidas.
MY192824A (en) Compound targeting il-23a and tnf-alpha and uses thereof
MX2016010451A (es) Benzoxaboroles microbicidamente activos.
EP3431580A4 (fr) Bactéries lactiques destinées à la préparation d'ensilage et additif destiné à la préparation d'ensilage
MX2015015162A (es) Agente de reduccion de acido urico.
MX2019011545A (es) Composiciones celulares y de andamio inyectables.
TW201614069A (en) Inhibitors of MYH7B and uses thereof
MX2019010330A (es) Formulaciones con mejora de la estabilidad.
PH12017500357A1 (en) Lactic acid bacteria-containing composition
EP3313380A4 (fr) Composition pour l'administration d'agents actifs à un animal
EP4083187A4 (fr) Promoteur de fermentation de bactérie lactique
SG10201906475UA (en) Agent for improving early insulin secretory capacity
EP3496553A4 (fr) Composition de dérivation du rumen d'ingrédients biologiquement actifs
SG11202003493VA (en) Composition for treating skin cell damage caused by fine dust, containing green tea-derived lactic acid bacteria
MY186332A (en) Pentosidine production inhibitor
MX2015008373A (es) Peptidos antimicrobianos, composiciones que los comprende y usos.